Wang, Hongyu, Bai, Ran, Wang, Yubing, Qu, Meihua, Zhou, You ![]() Item availability restricted. |
![]() |
PDF
- Accepted Post-Print Version
Restricted to Repository staff only until 10 January 2026 due to copyright restrictions. Download (2MB) |
Abstract
The forkhead box O1 (FOXO1), the first discovered member of the FoxO family, is a critical transcription factor predominantly found in insulin-secreting and insulin-sensitive tissues. In the pancreas of adults, FoxO1 expression is restricted to islet β cells. We determined that in human islet microarray datasets, FoxO1 expression is higher than other FoxO transcription factors. Our analyses of three human islet datasets revealed that FoxO1 expression tends to shows a negative correlation with type 2 diabetes and no correlation with body mass index (BMI) between individuals with low levels of HbA (or ND, non-diabetic) and high levels of HbA (or T2D, type 2 diabetes). However, FoxO1 function is multifaceted and mainly regulated by post-translational modifications including phosphorylation and deacetylation that involved in pancreatic β cell function and insulin sensitivity. This study summarized the molecular mechanisms underlying the role of FoxO1 activity in pancreatic β-cell dysfunction and insulin resistance in T2D. In addition, we discussed the therapeutic potential of FoxO1 inhibitors in diabetes treatment. [Abstract copyright: Copyright © 2025. Published by Elsevier Inc.]
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine |
Publisher: | Elsevier |
ISSN: | 0024-3205 |
Date of First Compliant Deposit: | 6 February 2025 |
Date of Acceptance: | 8 January 2025 |
Last Modified: | 06 Feb 2025 11:00 |
URI: | https://orca.cardiff.ac.uk/id/eprint/175653 |
Actions (repository staff only)
![]() |
Edit Item |